Astragaloside IV improves cognitive impairment in diabetes by inhibiting calpain-1/NLRP3 mediated microglial activation
International Immunopharmacology · 2025-12 · 167 · 115682
DOI: 10.1016/j.intimp.2025.115682 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-12. Verfasst von Xiaodi Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001, China. Hauptthemen laut MEDLINE: Calpain, NLR Family, Pyrin Domain-Containing 3 Protein, Microglia, Saponins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: First Affiliated Hospital of Jinzhou Medical University.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND: Astragaloside IV (ASIV) is known to protect cardiovascular and cerebrovascular function by regulating calpain-1. However, its impact on cognitive dysfunction in diabetes, as well as the underlying mechanisms, remains unknown. METHODS: A high-fat diet combined with streptozotocin (STZ) intraperitoneal injection was used to establish a mouse model of type 2 diabetes on calpain-1 (Capn1) EK684-/- mice and background-matched C57BL/6 mice. HT22 neurons and BV2 microglia were used for further mechanistic studies in vitro. Microglial polarization was observed by WB and multiple staining techniques. Inflammation and apoptosis as well as calpain-1/nucleotide-binding oligomerization domain (NOD)-like receptor pyrin domain containing 3(NLRP3) signaling pathway were observed both in vitro and vivo. RESULTS: ASIV and calpain-1 knockout have similar effects, both can improve the learning and memory impairment of diabetic mice, reduce the damage of hippocampal neurons, and preserve synaptic integrity. High glucose led to the polarization of microglia from M2 type to M1 type, accompanied by the increase of inflammatory factors. ASIV and calpain-1 inhibition reversed the M1 polarization and inflammatory response of microglia induced by high glucose to some extent, and this effect was accompanied by decreased apoptosis of neuronal HT22 cells. Mechanistic studies revealed that ASIV inhibited the increase of calpain-1, NLRP3 and ASC protein expression caused by high glucose. Calpain-1 inhibition did not further enhance the effect of ASIV on microglial polarization and NLRP3 pathway, whereas overexpression of calpain-1 abrogated the regulatory effects of ASIV on microglial polarization and NLRP3 pathway. CONCLUSIONS: ASIV inhibits microglial M1 polarization and inflammatory response by regulating calpain-1/NLRP3 signaling pathway, thereby alleviating neuronal damage and improving cognitive dysfunction in mice caused by high glucose.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001, China.
- Department of Cardiology, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001, China.
- Key Laboratory of Cardiovascular and Cerebrovascular Drug Research of Liaoning Province, Jinzhou Medical University, Jinzhou 121000, China.
- Liaoning Provincial Key Laboratory of Big Data for Neurological Diseases, Shenyang, Liaoning 110001, China.
- Department of Neurology, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001, China. Electronic address: baxiaohong@126.com.
Förderung
- First Affiliated Hospital of Jinzhou Medical University
Zitieren
APA
Wang, X., Jiang, H., Wang, H., Zhao, C., & Ba, X. (2025). Astragaloside IV improves cognitive impairment in diabetes by inhibiting calpain-1/NLRP3 mediated microglial activation. International Immunopharmacology, 167, 115682. https://doi.org/10.1016/j.intimp.2025.115682
Vancouver
Wang X, Jiang H, Wang H, Zhao C, Ba X. Astragaloside IV improves cognitive impairment in diabetes by inhibiting calpain-1/NLRP3 mediated microglial activation. International Immunopharmacology. 2025;167:115682. doi:10.1016/j.intimp.2025.115682
BibTeX
@article{Wang2025,
author = {Wang, Xiaodi and Jiang, Hexi and Wang, Hongxin and Zhao, Chuansheng and Ba, Xiaohong},
title = {Astragaloside IV improves cognitive impairment in diabetes by inhibiting calpain-1/NLRP3 mediated microglial activation},
journal = {International Immunopharmacology},
year = {2025},
volume = {167},
pages = {115682},
doi = {10.1016/j.intimp.2025.115682}
}
EUVIMED